BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12629732)

  • 21. Management of hyperuricemia and gout in CKD.
    Gaffo AL; Saag KG
    Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014
    [No Abstract]   [Full Text] [Related]  

  • 22. The PRPP synthetase spectrum: what does it demonstrate about nucleotide syndromes?
    Duley JA; Christodoulou J; de Brouwer AP
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1129-39. PubMed ID: 22132967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small disturbance, but a serious disease: the possible mechanism of D52H-mutant of human PRS1 that causes gout.
    Chen P; Li J; Ma J; Teng M; Li X
    IUBMB Life; 2013 Jun; 65(6):518-25. PubMed ID: 23509005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman.
    García-Pavía P; Torres RJ; Rivero M; Ahmed M; García-Puig J; Becker MA
    Arthritis Rheum; 2003 Jul; 48(7):2036-41. PubMed ID: 12847698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate.
    Fridman A; Saha A; Chan A; Casteel DE; Pilz RB; Boss GR
    Biochem J; 2013 Aug; 454(1):91-9. PubMed ID: 23734909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors altering purine metabolism in liver cells].
    Lalanne M; Des Rosiers C; Willemot J
    Rev Can Biol Exp; 1982 Mar; 41(1):65-71. PubMed ID: 6179131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PRPP synthetase deficiency].
    Imaeda H; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):435-7. PubMed ID: 9590093
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperuricemia associated with inborn errors of purine metabolism: screening, enzymatic and genetic diagnosis].
    Yamada Y
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():278-83. PubMed ID: 12629731
    [No Abstract]   [Full Text] [Related]  

  • 31. [Amidophosphoribosyltransferase].
    Iwahana H; Itakura M
    Nihon Rinsho; 1996 Dec; 54(12):3202-6. PubMed ID: 8976092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetic testing and gene-based testing for hyperuricemia and gout].
    Taniguchi A; Kamatani N
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():285-9. PubMed ID: 16416809
    [No Abstract]   [Full Text] [Related]  

  • 34. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 35. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inherited disorders of uric acid metabolism--classification, enzymatic- and DNA-diagnosis].
    Iwahana H; Itakura M
    Nihon Rinsho; 1996 Dec; 54(12):3303-8. PubMed ID: 8976110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a Salmonella typhimurium mutant defective in phosphoribosylpyrophosphate synthetase.
    Jochimsen BU; Hove-Jensen B; Garber BB; Gots JS
    J Gen Microbiol; 1985 Feb; 131(2):245-52. PubMed ID: 2580045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular nature of enzyme regulation in purine biosynthesis.
    Wyngaarden JB; Holmes EW
    Ciba Found Symp; 1977; (48):43-64. PubMed ID: 204465
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel PRPS1 gain-of-function mutation in a patient with congenital hyperuricemia and facial anomalies.
    Porrmann J; Betcheva-Krajcir E; Di Donato N; Kahlert AK; Schallner J; Rump A; Schröck E; Dobritzsch D; Roelofsen J; van Kuilenburg ABP; Tzschach A
    Am J Med Genet A; 2017 Oct; 173(10):2736-2742. PubMed ID: 28742244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A modified method for phosphoribosyl pyrophosphate synthesis].
    Filippova VN; Filanovskaya LI; Blinov MN
    Vopr Med Khim; 1975; 21(6):663-5. PubMed ID: 175573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.